Abstract: CRISPR/Cas9 system used for genome engineering in molecular biology is composed of two components: sgRNA which is a combination of original trRNA and crRNA, and Cas9 endonuclease. By delivering Cas9 and sgRNA into a cell, Cas9 is targeted to a given locus based on sequence complementary between sgRNA and cell genome, and further induces a double-strand break (DSB). Summary: Creative Biogene has developed a series of Cas9 expressing stable cell lines. Cas9 encoding gene is stably integrated into either random site, or AAVS1 safe harbor site of the human genome or ROSA26 safe harbor site of the mouse genome. Apart from HEK293 and HeLa cells, we have achieved Cas9 stable expression in several types of cancer cells which makes it convenient for scientists to study related gene functions of certain cancers.References: https://www.creative-biogene.com/products/cas9-stable-cell-lines.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Comparison Of Different Approaches To Generate Virtual Patient Populations Of Different Sizes For QSP Model Of Erythropoiesis
Galina Kolesova, Oleg Demin, Alexander Stepanov
Mesenchymal Stem Cells And Exosome Therapy for COVID‑19: Current Status and Future Perspective
Shraddha Singh Gautam
Quantitative systems pharmacology model for neurofilament L dynamics in Alzheimer's disease pathology
Polina Pchelintseva, Tatiana Karelina
Genetic basis of the hornwort’s carbon-concentrating mechanism
Peter Szovenyi et al.
Sequencing Technologies for DNA 5mC/5hmC Modifications